NDC 54838-566

Lamivudine

Lamivudine

Lamivudine is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Lannett Company, Inc.. The primary component is Lamivudine.

• Product ID: 54838-566_5e857323-7622-42d9-9224-2ff2da2ea16f
• NDC: 54838-566
• Product Type: Human Prescription Drug
• Proprietary Name: Lamivudine
• Generic Name: Lamivudine
• Dosage Form: Solution
• Route of Administration: ORAL
• Marketing Start Date: 2014-10-31
• Marketing Category: ANDA / ANDA
• Application Number: ANDA203564
• Labeler Name: Lannett Company, Inc.
• Substance Name: LAMIVUDINE
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 54838-566-70

240 mL in 1 BOTTLE, PLASTIC (54838-566-70)

• Marketing Start Date: 2014-10-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 54838-566-70 [54838056670]

Lamivudine SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA203564
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-01-30

Drug Details

Active Ingredients

Ingredient	Strength
LAMIVUDINE	10 mg/mL

OpenFDA Data

• SPL SET ID: 5b7ad852-94ff-4e8c-b53e-793a4c0a9db4
• Manufacturer:
  • Lannett Company, Inc.
• UNII:
  • 2T8Q726O95
• RxNorm Concept Unique ID - RxCUI:
  • 199148
• UPC Code:
  • 0354838566703

Pharmacological Class

• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

Medicade Reported Pricing

54838056670 LAMIVUDINE 10 MG/ML ORAL SOLN

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Lamivudine" or generic name "Lamivudine"

NDC	Brand Name	Generic Name
0904-6583	LAMIVUDINE	lamivudine
10135-605	Lamivudine	Lamivudine
31722-001	lamivudine	lamivudine
31722-752	Lamivudine	Lamivudine
31722-753	Lamivudine	Lamivudine
31722-754	Lamivudine	Lamivudine
33342-001	Lamivudine	Lamivudine
33342-002	Lamivudine	Lamivudine
68180-603	Lamivudine	Lamivudine
68180-602	Lamivudine	Lamivudine
69097-167	LAMIVUDINE	LAMIVUDINE
69097-166	LAMIVUDINE	LAMIVUDINE
70518-0540	Lamivudine	Lamivudine
70518-0440	Lamivudine	Lamivudine
70518-0513	Lamivudine	Lamivudine
70518-0690	Lamivudine	Lamivudine
70518-1083	Lamivudine	Lamivudine
70518-1084	Lamivudine	Lamivudine
70518-1634	Lamivudine	Lamivudine
70518-1933	Lamivudine	Lamivudine
50268-460	Lamivudine	Lamivudine
50268-459	Lamivudine	Lamivudine
50742-623	Lamivudine	Lamivudine
50742-624	Lamivudine	Lamivudine
51293-832	Lamivudine	Lamivudine
53808-0843	LAMIVUDINE	LAMIVUDINE
53808-0844	LAMIVUDINE	LAMIVUDINE
54838-566	Lamivudine	Lamivudine
57237-274	Lamivudine	Lamivudine
60429-354	LAMIVUDINE	LAMIVUDINE
60687-362	Lamivudine	Lamivudine
60429-353	LAMIVUDINE	LAMIVUDINE
60505-3250	Lamivudine	Lamivudine
60505-3252	LAMIVUDINE	LAMIVUDINE
60505-3251	LAMIVUDINE	LAMIVUDINE
63629-5014	Lamivudine	Lamivudine
64380-711	Lamivudine	Lamivudine
64330-001	Lamivudine	Lamivudine
64380-710	Lamivudine	Lamivudine
65862-055	Lamivudine	Lamivudine
65862-026	Lamivudine	Lamivudine
65862-552	Lamivudine	Lamivudine
65862-553	Lamivudine	Lamivudine
65862-025	Lamivudine	Lamivudine
66993-478	Lamivudine	Lamivudine
69967-003	Lamivudine	Lamivudine
69967-004	Lamivudine	Lamivudine
70518-2067	Lamivudine	Lamivudine
70518-2070	Lamivudine	Lamivudine
0173-0662	EPIVIR	lamivudine